Literature DB >> 10430744

Role of peroxynitrite in airway microvascular hyperpermeability during late allergic phase in guinea pigs.

H Sugiura1, M Ichinose, T Oyake, Y Mashito, Y Ohuchi, N Endoh, M Miura, S Yamagata, A Koarai, T Akaike, H Maeda, K Shirato.   

Abstract

We investigated the role of peroxynitrite, which is formed by a rapid reaction between nitric oxide (NO) and superoxide anion (O(2)(-)), in the airway microvascular hyperpermeability during the late allergic response (LAR) in sensitized guinea pigs in vivo. The occurrence of LAR was assessed as a 100% increase in the transpulmonary pressure, which was monitored by the esophageal catheter technique. Airway microvascular permeability was assessed by Monastral blue dye trapping between the endothelium using an image analyzer. In the LAR phase (4 to 6 h after antigen inhalation), microvascular hyperpermeability and eosinophil infiltration within the airway wall were observed. NO production and xanthine oxidase (XO)/xanthine dehydrogenase activity, which are responsible for O(2)(-) production, were enhanced during the LAR. Peroxynitrite formation assessed by nitrotyrosine immunostaining was also exaggerated at that time. The microvascular hyperpermeability during the LAR was largely reduced by NO synthase inhibitor (L-NAME, 72.7% inhibition; p < 0.05), XO inhibitor (AHPP, 60.8% inhibition; p < 0. 05) and peroxynitrite scavenger (ebselen, 81.0% inhibition; p < 0. 05). L-NAME had a small but significant inhibitory effect on airway eosinophil accumulation, but AHPP and ebselen had no effect. These results suggest that excessive production of O(2)(-) and NO occurs in the LAR. These two molecules appear to cause airway microvascular hyperpermeability via peroxynitrite formation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430744     DOI: 10.1164/ajrccm.160.2.9807160

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  8 in total

1.  Role of nitric oxide and superoxide in allergen-induced airway hyperreactivity after the late asthmatic reaction in guinea-pigs.

Authors:  J de Boer; H Meurs; L Flendrig; M Koopal; J Zaagsma
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

2.  Correlation between change in pulmonary function and suppression of reactive nitrogen species production following steroid treatment in COPD.

Authors:  H Sugiura; M Ichinose; S Yamagata; A Koarai; K Shirato; T Hattori
Journal:  Thorax       Date:  2003-04       Impact factor: 9.139

3.  Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase.

Authors:  Anastasia M Makarova; Tatiana V Lebedeva; Taher Nassar; Abd Al-Roof Higazi; Jing Xue; Maria E Carinato; Khalil Bdeir; Douglas B Cines; Victoria Stepanova
Journal:  J Biol Chem       Date:  2011-05-03       Impact factor: 5.157

4.  Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration.

Authors:  Karina Ckless; Anniek Lampert; Jessica Reiss; David Kasahara; Matthew E Poynter; Charles G Irvin; Lennart K A Lundblad; Ryan Norton; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 5.  Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives.

Authors:  Harm Maarsingh; Johan Zaagsma; Herman Meurs
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

6.  Arginase and arginine dysregulation in asthma.

Authors:  Renée C Benson; Karen A Hardy; Claudia R Morris
Journal:  J Allergy (Cairo)       Date:  2011-04-26

7.  Increase of nitrosative stress in patients with eosinophilic pneumonia.

Authors:  Kanako Furukawa; Hisatoshi Sugiura; Kazuto Matsunaga; Tomohiro Ichikawa; Akira Koarai; Tsunahiko Hirano; Satoru Yanagisawa; Yoshiaki Minakata; Keiichiro Akamatsu; Masae Kanda; Manabu Nishigai; Masakazu Ichinose
Journal:  Respir Res       Date:  2011-06-17

Review 8.  Uncovering the Role of Oxidative Imbalance in the Development and Progression of Bronchial Asthma.

Authors:  Luiz H C Vasconcelos; Sarah R D Ferreira; Maria da C C Silva; Paula B Ferreira; Iara L L de Souza; Fabiana de A Cavalcante; Bagnólia A da Silva
Journal:  Oxid Med Cell Longev       Date:  2021-03-03       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.